James C. Foster, a Director at Charles River Laboratories International, Inc. (CRL), reported a sale of 24,042 shares on October 22, 2026. The transaction, valued at approximately $8.41 million, was executed at a price of $350.00 per share.
This sale by Mr. Foster represents a significant divestiture of his holdings in the company. It is important to note that insider sales can occur for a variety of reasons, including personal financial planning, diversification of assets, or tax considerations, and do not inherently signal a negative view of the company's prospects.
The broader context of insider activity at Charles River Laboratories shows a mix of transactions in recent weeks. Prior to this sale, other executives, including Shannon M. Parisotto, have also engaged in share sales. Conversely, Glenn Coleman recently made a small purchase of shares, which is often viewed as a bullish indicator.